Trevi Therapeutics News

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L

Sep 9 17:06 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L

Sep 5 17:03 ET

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 3 16:41 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Meeker David P

Aug 29 16:56 ET

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 27 16:15 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCIASCIA THOMAS

Aug 21 16:05 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCIASCIA THOMAS

Aug 16 16:49 ET

Trevi Therapeutics | 144/A: Others

Aug 15 17:17 ET

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 15 16:28 ET

Trevi Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:48 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

Aug 8 16:17 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(1.98%),Steven Salamon(1.98%), etc.

Jul 11 17:54 ET

Trevi Therapeutics | SCHEDULE 13G/A: Others

Jul 10 16:20 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T

Jun 14 16:47 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Meeker David P

Jun 14 16:39 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heffernan Michael Thomas

Jun 14 16:39 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cassella James V

Jun 14 16:38 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Colangelo Dominick

Jun 14 16:37 ET

Trevi Therapeutics | 8-K: Current report

Jun 13 17:05 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCIASCIA THOMAS

May 31 16:19 ET